VetOne Meloxidyl (Meloxicam) 1.5 mg/ml Oral Suspension is a non-steroidal anti-inflammatory (NSAID) indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Dogs (6 months of age and older)

Helps control pain and inflammation associated with osteoarthritis in dogs. Easy to use oral suspension.

Meloxicam works by reducing hormones that cause pain and inflammation in the body.

GI abnormalities (vomiting, soft stools, diarrhea, and inappetance) were the most common adverse reactions associated with the administration of meloxicam.

Meloxicam 1.5 mg/ml

Contact your nearest emergency animal hospital.

Keep away from children and animals. Precautions : The safe use of VetOne Meloxidyl (Meloxicam) Oral Suspension in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated. Meloxicam is not recommended for use in dogs with bleeding disorders, as safety has not been established in dogs with these disorders. As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Sensitivity to drug-associated adverse events varies with the individual patient. Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID. Patients at greatest risk for renal toxicity are those that are dehydrated, on concomitant diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since NSAIDs possess the potential to induce gastrointestinal ulcerations and/or perforations, concomitant use with other anti-inflammatory drugs, such as NSAIDs or corticosteroids, should be avoided. If additional pain medication is needed after administration of the total daily dose of VetOne Meloxidyl (Meloxicam) Oral Suspension, a non-NSAID or non-corticosteroid class of analgesia should be considered. The use of another NSAID is not recommended. Consider appropriate washout times when switching from corticosteroid use or from one NSAID to another in dogs. The use of concomitantly protein-bound drugs with VetOne Meloxidyl (Meloxicam) Oral Suspension has not been studied in dogs. Commonly used protein-bound drugs include cardiac, anticonvulsant and behavioral medications. The influence of concomitant drugs that may inhibit metabolism of VetOne Meloxidyl (Meloxicam) Oral Suspension has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy. Warnings Not for use in humans. Consult a physician in case of accidental ingestion by humans. For oral use in dogs only. As with any NSAID all dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to and periodically during administration. Owner should be advised to observe their dog for signs of potential drug toxicity and be given a client information sheet about VetOne Meloxidyl. Contraindications Dogs with known hypersensitivity to meloxicam should not receive VetOne Meloxidyl (Meloxicam) Oral Suspension. Do not use VetOne Meloxidyl (Meloxicam) Oral Suspension in cats. Acute renal failure and death have been associated with the use of meloxicam in cats.

10 ml, 32 ml, 100 ml or 200 ml bottles

VetOne